Hyporegenerative anemia associated with Rh hemolytic disease: Treatment failure of recombinant erythropoietin

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 8, 2002, Pages 689-693

  Pessler, Frank ^a   Hart, David ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

Erythroblastosis fetalis; Erythropoietin; Hyporegenerative anemia; Intrahepatic cholestasis; Late anemia; Rh genotyping; Rh isoimmunization

Indexed keywords

FERROUS SULFATE; RECOMBINANT ERYTHROPOIETIN; RHESUS ANTIBODY;

ANEMIA; ANTIBODY TITER; APGAR SCORE; CASE REPORT; CONFERENCE PAPER; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; EXON; FEMALE; FETUS HYDROPS; GENOTYPE; HEMOLYTIC ANEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; IRON OVERLOAD; IRON THERAPY; LIVER TOXICITY; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETICULOCYTOSIS; RHESUS ISOIMMUNIZATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANEMIA; BLOOD TRANSFUSION, INTRAUTERINE; CHOLESTASIS, INTRAHEPATIC; DRUG RESISTANCE; ERYTHROBLASTOSIS, FETAL; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRITINS; HEPATOMEGALY; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT, NEWBORN; IRON OVERLOAD; ISOANTIBODIES; JAUNDICE, NEONATAL; PHOTOTHERAPY; PREGNANCY; RETICULOCYTE COUNT; RH ISOIMMUNIZATION; TIME FACTORS;

EID: 0036842492     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200211000-00019     Document Type: Conference Paper

References (22)

1. Smith CH. Chronic congenital aregenerative anemia (Pure red-cell anemia) associated with iso-immunization by the blood group factor A. Blood 1949;4:697-705.
2. Giblett ER, Varela JE, Finch CA. Damage to the bone marrow due to Rh antibody. Pediatrics 1956;17:37-44.
3. Koenig JM, Ashton RD, De Vore GR, Christensen RD. Late hyporegenerative anemia in Rh hemolytic disease. J Pediatr 1989;115:315:-8.
4. Thorp JA, O'Connor T, Callenbach J, et al. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease. Am J Obstet Gynecol 1991;165:79-81.
5. Burk CD, Malatack JJ, Ramsey G. Misleading Rh phenotype and severe prolonged anemia in hemolytic disease of the newborn. Am J Dis Child 1987;141:712-3.
6. Hayde M, Widness A, Pollack A, et al. Rhesus isoimmunization: Increased hemolysis during early infancy. Pediatr Res 1997;41:716-21.
7. Ohls RK, Wirkus PE, Christensen RD. Recombinant erythropoietin as treatment of the late hyporegenerative anemia of Rh hemolytic disease. Pediatrics 1992;90:678-80.
8. Scaradavou A, Inglis S, Peterson P, et al. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: Use of EPO to treat the late anemia. J Pediatr 1993;123:279-84.
9. Zuppa AA, Maragliano G, Scapillati ME, et al. Recombinant EPO in the prevention of late anemia in intrauterine transfused neonates with Rh-hemolytic disease. Fetal Diagn Ther 1999;14:270-4.
10. Ovali F, Samanci N, Dagoglu T. Management of late anemia in rhesus hemolytic disease: Use of recombinant human EPO (A pilot study). Pediatr Res 1996;39:831-4.
11. Lo YMD, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-8.
12. Millard DD, Gidding SS, Socol ML, et al. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. J Pediatr 1990;117:447-54.
13. Al-Alaiyan S, Omran AA. Late hyporegenerative anemia in neonates with rhesus hemolytic disease. J Perinat Med 1999;27:112-5.
14. Dallacasa P, Ancora G, Miniero R, et al. Erythropoietin course in newborns with Rh hemolytic disease transfused and not transfused in utero. Pediatr Res 1996;40:357-60.
15. Kling PJ, Schmidt RL, Roberts RA, Widness JA. Serum erythropoietin levels during infancy: Associations with erythropoiesis. J Pediatr 1996;128:791-6.
16. Dillon HC, Krivit W. Serial study of bone marrow in hemolytic disease of the newborn (Erythroblastosis fetalis). Pediatrics 1959;23:314-22.
17. Rearden A, Masouredis SP. Blood group D antigen content of nucleated red cell precursors. Blood 1977;50:981-6.
18. Drueke T. Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant 2001;16(suppl 7):25-8.
19. Koenig JM, Christensen RD. Neutropenia and thrombocytopenia in infants with Rh hemolytic disease. J Pediatr 1989;114:625-30.
20. Dunn PM. Obstructive jaundice, liver damage, and Rh haemolytic disease of the newborn. Jewish Memorial Bull (Commemorative Issue) 1965:10:94-107.
21. Nasrat HA, Nicolini U, Nicolaides P, et al. The effect of intrauterine intravascular blood transfusion on iron metabolism in fetuses with Rh alloimmunization. Obstet Gynecol 1991;77:558-62.
22. Lasker MR, Eddleman K, Toor AH. Neonatal hepatitis and excessive hepatic iron deposition following intrauterine blood transfusion. Am J Perinatol 1995;12:14-7.